D360 Probiotic & Fiber
Natural health product licensed in Canada
- Other names
- ProFibre
- Licence holder
- Ignite Pharma Inc.
- NPN or DIN-HM
- 80077754
- Status
- Inactive licence
- Licence date
- 25 May 2017
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus rhamnosus Source : Lactobacillus rhamnosus - Cellule entière | 24,000,000 CFU/g | Not calculated |
| Lactiplantibacillus plantarum Source : Lactobacillus plantarum - Cellule entière | 74,000,000 CFU/g | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : Lactobacillus delbrueckii subsp. blugaricus- Whole | 1,200,000 CFU/g | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 12,000,000 CFU/g | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 8,400,000 CFU/g | Not calculated |
| Plantago ovata Source : Plantago ovata husk | 69.4 % | Not calculated |
| Inuline Source : Cichorium intybus - racine | 30.2 % | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 10 years ; maximum: 14 years | minimum: 1 Cuillère à thé ; maximum: 1 Cuillère à thé | minimum: 2 days ; maximum: 2 days |
| Adultes et adolescents | minimum: 15 years | minimum: 1 Cuillère à thé ; maximum: 1 Cuillère à thé | minimum: 2 days ; maximum: 2 days |
| Enfants | minimum: 6 years ; maximum: 9 years | minimum: 1 Cuillère à thé ; maximum: 1 Cuillère à thé | minimum: 2 days ; maximum: 2 days |
Uses authorised in Canada
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of fiber for the maintenance of good health. Helps to support and maintain a healthy digestive system. Helps to simulate the growth of healthy bacteria in the intestine/gut. Helps provide gentle relief of constipation and/or irregularity. Bulk-forming laxative. Provide(s) gentle relief of constipation and/or irregularity. Promote(s) bowel movements by increasing bulk volume and water content.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity has been known to occur. In which case, discontinue use. May cause temporary gas and/or bloating.
- Contre-indications
Contains traces of soya and traces of milk products at a level which would not affect lactose intolerance sufferers. If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. Do not use if you have difficulty swallowing. Consult a health care practitioner prior to use if you have diabetes mellitus in which blood sugar is difficult to regulate.
- Précautions et mises en garde
If you have fever, vomiting, nausea, bloody diarrhea or sever abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occurs and/or persists beyond 3 days, discontinue use and consult a health care practitioner. If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opiods, loperamide). If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, do not use. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product.
Source
Official Health Canada record, licence 80077754
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.